Jump to content

AMG-1

From Wikipedia, the free encyclopedia

This is an old revision of this page, as edited by Edgar181 (talk | contribs) at 21:36, 7 June 2019 (minor cleanup). The present address (URL) is a permanent link to this revision, which may differ significantly from the current revision.

AMG-1
Identifiers
  • (6aR,10aR)-3-(Hept-1-ynyl)-6,6,9-trimethyl-6a,7,10,10a-tetrahydrobenzo[c]chromen-1-ol
CAS Number
PubChem CID
ChemSpider
ChEMBL
Chemical and physical data
FormulaC23H30O2
Molar mass338.491 g·mol−1
3D model (JSmol)
  • CC=3CC1c2c(O)cc(C#CCCCCC)cc2OC(C)(C)C1CC=3
  • InChI=1S/C23H30O2/c1-5-6-7-8-9-10-17-14-20(24)22-18-13-16(2)11-12-19(18)23(3,4)25-21(22)15-17/h11,14-15,18-19,24H,5-8,12-13H2,1-4H3/t18-,19-/m1/s1 checkY
  • Key:PYCLMAJRHLLHNO-RTBURBONSA-N checkY
 ☒NcheckY (what is this?)  (verify)

AMG-1 (part of the AM cannabinoid series) is an analgesic drug which is a cannabinoid agonist. It is a derivative of Δ8THC with a rigidified and extended 3-position side chain. AMG-1 is a potent agonist at both CB1 and CB2 with moderate selectivity for CB1, with a Ki of 0.6 nM at CB1 vs 3.1 nM at CB2.[1][2]

See also

References

  1. ^ Papahatjis, Demetris P.; Nikas, Spyros P.; Kourouli, Therapia; Chari, Ravi; Xu, Wei; Pertwee, Roger G.; Makriyannis, Alexandros (2003). "Pharmacophoric Requirements for the Cannabinoid Side Chain. Probing the Cannabinoid Receptor Subsite at C1'". Journal of Medicinal Chemistry. 46 (15): 3221–3229. doi:10.1021/jm020558c. ISSN 0022-2623. PMID 12852753.
  2. ^ Keimowitz, Alison R.; Martin, Billy R.; Razdan, Raj K.; Crocker, Peter J.; Mascarella, S. Wayne; Thomas, Brian F. (2000). "QSAR Analysis of Δ8-THC Analogues: Relationship of Side-Chain Conformation to Cannabinoid Receptor Affinity and Pharmacological Potency". Journal of Medicinal Chemistry. 43 (1): 59–70. doi:10.1021/jm9902281. ISSN 0022-2623. PMID 10633038.